Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 1.211
Filter
2.
Genes (Basel) ; 15(5)2024 Apr 24.
Article in English | MEDLINE | ID: mdl-38790165

ABSTRACT

Adams-Oliver syndrome is a rare inherited condition characterized by scalp defects and limb abnormalities. It is caused by variants in different genes such as ARHGAP31. Here, we used an interdisciplinary approach to study a family with lower limb anomalies. We identified a novel variant in the ARHGAP31 gene that is predicted to result in a truncated protein with a constitutively activated catalytic site due to the loss of 688 amino acids involved in the C-terminal domain, essential for protein auto-inhibition. Pathogenic variants in ARHGAP31 exon 12, leading to a premature protein termination, are associated with Adams-Oliver syndrome. Bioinformatic analysis was useful to elucidate the impact of the identified genetic variant on protein structure. To better understand the impact of the identified variant, 3D protein models were predicted for the ARHGAP31 wild type, the newly discovered variant, and other pathogenetic alterations already reported. Our study identified a novel variant probably involved in Adams-Oliver syndrome and increased the evidence on the phenotypic variability in patients affected by this syndrome, underlining the importance of translational research, including experimental and bioinformatics analyses. This strategy represents a successful model to investigate molecular mechanisms involved in syndrome occurrence.


Subject(s)
Ectodermal Dysplasia , GTPase-Activating Proteins , Pedigree , Phenotype , Scalp Dermatoses , Humans , GTPase-Activating Proteins/genetics , Scalp Dermatoses/genetics , Scalp Dermatoses/congenital , Scalp Dermatoses/pathology , Ectodermal Dysplasia/genetics , Ectodermal Dysplasia/pathology , Male , Female , Mutation , Limb Deformities, Congenital/genetics , Phosphoproteins
4.
BMJ Case Rep ; 17(2)2024 Feb 15.
Article in English | MEDLINE | ID: mdl-38359953

ABSTRACT

Cutis verticis gyrata (CVG) is a very rare benign disorder characterised by convoluted folds and deep furrows of the scalp that mimic cerebral sulci and gyri. Associations with other pathologies as neuropsychiatric and/or ophthalmologic disorders, secondary cases to inflammatory or neoplastic processes, as well as cases associated to genetic disorders as Turner's syndrome have been reported, but there is no literature describing an association with a congenital structural heart defect and no other underlying condition. We report a case of primary CVG in a 3-week-old female infant associated with an echocardiographic diagnosis of cor triatriatum. Other systemic examination findings and investigations were unremarkable, and the patient has normal neurodevelopment at 1 year old. Aside from the neuropsychiatric and ophthalmologic pathologies commonly associated with primary non-essential CVG, it should be noted that isolated congenital cardiac lesions are also possible, so as to increase our index of suspicion in patients with the disorder.


Subject(s)
Connective Tissue Diseases , Heart Defects, Congenital , Scalp Dermatoses , Skin Abnormalities , Humans , Female , Infant , Scalp Dermatoses/complications , Scalp Dermatoses/diagnosis , Scalp Dermatoses/pathology , Scalp/pathology , Skin Abnormalities/diagnosis , Heart Defects, Congenital/diagnosis , Heart Defects, Congenital/diagnostic imaging , Diagnosis, Differential , Connective Tissue Diseases/diagnosis , Rare Diseases/diagnosis
6.
J R Coll Physicians Edinb ; 53(4): 255-257, 2023 12.
Article in English | MEDLINE | ID: mdl-37649190

ABSTRACT

Epidermal growth factor receptor inhibitors are anti-tumour agents that are frequently used for the treatment of neoplastic disorders. In addition to their cutaneous adverse effects, these drugs can rarely lead to erosive pustular dermatosis of the scalp. We report a case of a 67-year-old female who developed erosive pustular dermatosis of the scalp after being started on erlotinib from a trichoscopic perspective, which has been described in literature only once till now.


Subject(s)
Antineoplastic Agents , Scalp Dermatoses , Female , Humans , Aged , Scalp Dermatoses/chemically induced , Scalp Dermatoses/drug therapy , Scalp Dermatoses/pathology , Erlotinib Hydrochloride/adverse effects , Scalp/pathology , Antineoplastic Agents/therapeutic use
9.
Pediatr Dermatol ; 40(6): 1155-1156, 2023.
Article in English | MEDLINE | ID: mdl-37253654

ABSTRACT

Alopecic and aseptic nodules of the scalp (AANS) and dissecting cellulitis of the scalp (DCS) are rare, closely related conditions of young men that exclusively affect the hair-bearing scalp. We describe a 9-year-old boy who presented with a 6-year history of chronically relapsing, sterile, partially scarring nodules of the scalp and facial skin. Histopathology revealed mixed inflammatory infiltrates consisting of neutrophils, macrophages, lymphocytes, and plasma cells in the deep dermis, consistent with the morphological pattern of suppurative, partly granulomatous dermatitis. The present atypical case is characterized by prepubertal onset and facial involvement which, to our knowledge, has not yet been described before, may be included in the spectrum of "typical" AANS and "typical" DCS.


Subject(s)
Cellulitis , Scalp Dermatoses , Skin Diseases, Genetic , Male , Humans , Child , Cellulitis/diagnosis , Cellulitis/pathology , Scalp/pathology , Alopecia , Scalp Dermatoses/diagnosis , Scalp Dermatoses/pathology
10.
Eur Rev Med Pharmacol Sci ; 27(3): 1023-1026, 2023 02.
Article in English | MEDLINE | ID: mdl-36808348

ABSTRACT

BACKGROUND: Erosive pustular dermatosis of the scalp (EPDS) is a rare inflammatory disorder of elderly individuals, characterized by relapsing pustular and eroded lesions of the scalp, which may lead to scarring alopecia. Treatment is challenging and classically based on topical and/or oral corticosteroids. CASE REPORT: From 2008 to 2022, we treated fifteen cases of EPDS. We used mainly topical and systemic steroids with good results. Nevertheless, several non-steroidal topical drugs have been described in literature for the treatment of EPDS. We have carried out a brief review of these treatments. CONCLUSIONS: Topical calcineurin inhibitors represent a valuable alternative to steroids to avoid skin atrophy. Emerging evidence about other topical treatments, such as calcipotriol, dapsone, zinc oxide, together with photodynamic therapy, are evaluated in our review.


Subject(s)
Scalp Dermatoses , Scalp , Humans , Aged , Scalp/pathology , Scalp Dermatoses/drug therapy , Scalp Dermatoses/pathology , Administration, Topical , Dapsone/therapeutic use , Alopecia/drug therapy
12.
Am J Med Genet A ; 188(11): 3318-3323, 2022 11.
Article in English | MEDLINE | ID: mdl-36059114

ABSTRACT

Aplasia cutis congenita (ACC) of the scalp and terminal transverse limb defects (TTLD) are the characteristic findings of Adams-Oliver syndrome (AOS). The variable clinical spectrum further includes cardiac, neurologic, renal, and ophthalmological findings. Associated genes in AOS are in the Notch and the CDC42/Rac1 signaling pathways. Both autosomal-dominant and autosomal-recessive inheritances have been reported, the latter with pathogenic variants in DOCK6 or EOGT. The EOGT-associated recessive type of AOS has been postulated to present a more favorable prognosis. We here report a 12-year-old girl from a refugee family of Iraq with consanguineous parents. She was born with a severe phenotype of AOS presenting a large ACC of the scalp with an underlying skull defect, which was often infected and inflamed. Afterward, additional ulceration developed. Furthermore, the girl showed microcephaly, TTLD on both hands and feet, and neurological findings: spastic paresis, epilepsy and suspicion of intellectual deficit. Molecular genetic analysis (next-generation sequencing) revealed a novel frameshift mutation in the EOGT gene in Exon 13 in homozygous constellation: c.1013dupA p.(Asn338Lysfs*24). A biopsy within an ulceration at the scalp ACC showed a cutaneous squamous cell carcinoma (cSCC) with local invasive growth into the dura, the meninges, and the cortex. Treatment including surgical resection and focal irradiation was not curative and the girl deceased 6 months after initial diagnosis. This report on a patient with AOS and an autosomal-recessive EOGT gene variant dying of a local aggressive cSCC at an ACC lesion shows that close monitoring of ACC is essential.


Subject(s)
Carcinoma, Squamous Cell , Ectodermal Dysplasia , Limb Deformities, Congenital , Scalp Dermatoses , Skin Neoplasms , Ectodermal Dysplasia/diagnosis , Ectodermal Dysplasia/genetics , Ectodermal Dysplasia/pathology , Female , Frameshift Mutation , Humans , Limb Deformities, Congenital/genetics , Mutation , N-Acetylglucosaminyltransferases/genetics , Scalp/pathology , Scalp Dermatoses/congenital , Scalp Dermatoses/diagnosis , Scalp Dermatoses/genetics , Scalp Dermatoses/pathology , Skin Neoplasms/diagnosis , Skin Neoplasms/genetics , Skull/pathology
13.
Dermatol Ther ; 35(7): e15584, 2022 07.
Article in English | MEDLINE | ID: mdl-35569130

ABSTRACT

BACKGROUND: Erosive pustular dermatosis of the scalp (EPDS) is an inflammatory cutaneous disorder typically affecting sun-damaged skin of mature individuals. Clinical features of EPDS include sterile pustules and chronic crusted erosions that can be hyperkeratotic and lead to scarring alopecia, atrophy, and telangiectasia. While the condition occurs on sun-damaged skin, a relationship with non-melanoma skin cancer (NMSC) has not been investigated. OBJECTIVES: Here we attempted to identify cases of NMSC developing in the setting of EPDS. METHODS: Retrospective review of EPDS cases in a dermatology practice. RESULTS: Six patients with mean (range) age 82 (65-92) years that developed NMSC in the setting of EPDS are reported. Five patients had skin phototype I or II associated with substantial solar elastosis. Four patients had history of NMSC. Four patients developed squamous cell carcinoma and two patients basal cell carcinoma on the scalp in the setting of EPDS. A morphologic change in an EPDS lesion, such as a crusted plaque becoming nodular and/or growing significantly within a relatively short period of time, prompted a biopsy that revealed NMSC. CONCLUSIONS: NMSC may develop in the setting of EPDS. Possible mechanisms underlying this association include the chronic inflammation associated with EPDS and ultraviolet light exposure. It is crucial to promptly obtain a biopsy in EPDS cases showing signs suspicious for NMSC. Further studies are required to confirm whether NMSC shows a higher prevalence in the setting of EPDS.


Subject(s)
Scalp Dermatoses , Skin Diseases, Vesiculobullous , Skin Neoplasms , Aged, 80 and over , Alopecia/pathology , Humans , Scalp/pathology , Scalp Dermatoses/diagnosis , Scalp Dermatoses/etiology , Scalp Dermatoses/pathology , Skin Diseases, Vesiculobullous/diagnosis , Skin Diseases, Vesiculobullous/etiology , Skin Diseases, Vesiculobullous/pathology , Skin Neoplasms/diagnosis , Skin Neoplasms/pathology
14.
An Bras Dermatol ; 97(3): 348-357, 2022.
Article in English | MEDLINE | ID: mdl-35379508

ABSTRACT

Lichen planopilaris and frontal fibrosing alopecia are primary scarring alopecias where diagnosis can be suggested by clinical and trichoscopy features, especially in the early stages, but scalp biopsy is the standard exam for definitive diagnosis. Frontal fibrosing alopecia is considered a variant of lichen planopilaris, as the histopathological findings are similar, with a perifollicular lymphohistiocytic infiltrate, sometimes with a lichenoid pattern. A thorough clinical examination, trichoscopy and photographic documentation are essential to assess the evolution and therapeutic response. To date, there are no validated treatments or guidelines for these diseases, but there are recommendations that vary with the individual characteristics of each patient. This article presents a comprehensive review of the literature, including an update on topics related to the diagnosis, follow-up, histopathological aspects and available treatments for lichen planopilaris and frontal fibrosing alopecia, highlighting their similarities, differences and peculiarities.


Subject(s)
Lichen Planus , Scalp Dermatoses , Alopecia/diagnosis , Alopecia/drug therapy , Alopecia/pathology , Humans , Lichen Planus/diagnosis , Lichen Planus/drug therapy , Lichen Planus/pathology , Scalp/pathology , Scalp Dermatoses/diagnosis , Scalp Dermatoses/drug therapy , Scalp Dermatoses/pathology
15.
Clin Exp Dermatol ; 47(1): 197-199, 2022 Jan.
Article in English | MEDLINE | ID: mdl-34407257

ABSTRACT

The novel use of cryolipolysis via icepacks, a readily available and inexpensive device, is described for lipoedematous scalp with subjective and objective relief. This is a simple solution to a troublesome, intractable condition and may readily be utilized for patient benefit. Juxtaposing pre and post clinical images.


Subject(s)
Alopecia/complications , Cryotherapy/methods , Lipedema/complications , Lipedema/therapy , Scalp Dermatoses/complications , Scalp Dermatoses/therapy , Alopecia/pathology , Dermoscopy , Female , Humans , Lipedema/pathology , Middle Aged , Scalp Dermatoses/pathology
16.
Clin Exp Dermatol ; 47(3): 568-572, 2022 Mar.
Article in English | MEDLINE | ID: mdl-34559911

ABSTRACT

Angiolymphoid hyperplasia with eosinophilia (ALHE) is a rare benign vascular proliferation, which manifests as characteristic red nodules and papules, mostly located on the scalp and periauricular regions. Patients seek treatment for both aesthetic and functional reasons, as lesions may ulcerate, bleed and itch. Many therapeutic approaches have been reported, with variable success, and relapse remains a troublesome issue. The aim of this study was to report our experience treating ALHE using percutaneous ethanol sclerotherapy (PES). We present a retrospective case series of three patients treated with PES (1-2 treatment sessions each). All patients had tried and failed other treatments prior to this intervention, but following PES treatment, all patients demonstrated significant improvement, which was sustained at follow-up (range 8-17 months after first treatment). Adverse effects were tolerable and transient. This case series demonstrates PES as a promising treatment for recalcitrant ALHE.


Subject(s)
Angiolymphoid Hyperplasia with Eosinophilia/therapy , Ethanol/administration & dosage , Scalp Dermatoses/therapy , Sclerotherapy/methods , Administration, Cutaneous , Adult , Aged , Angiolymphoid Hyperplasia with Eosinophilia/pathology , Female , Humans , Retrospective Studies , Scalp Dermatoses/pathology , Treatment Outcome
17.
Am J Clin Dermatol ; 22(5): 681-692, 2021 Sep.
Article in English | MEDLINE | ID: mdl-34347282

ABSTRACT

Lichen planopilaris is a primary lymphocytic cicatricial alopecia that commonly presents with hair loss at the vertex or parietal scalp. Patients may also have associated scalp itching, burning or tenderness. Due to scarring, hair loss is typically permanent. The main goals of treatment are reducing symptoms and preventing disease progression and further hair loss. Currently, the literature has limited evidence on treatments for this difficult condition, and most available evidence is from case reports and case series. Furthermore, the evidence shows a varied response to therapy, with frequent reports of poor response. This article reviews the diagnosis of this rare disease, summarize the currently available treatments, and provide insights and practices from alopecia experts.


Subject(s)
Lichen Planus/diagnosis , Lichen Planus/therapy , Scalp Dermatoses/diagnosis , Scalp Dermatoses/therapy , Humans , Scalp/pathology , Scalp Dermatoses/pathology
18.
Article in English | MEDLINE | ID: mdl-34245526

ABSTRACT

Cutis verticis gyrata is a rare disorder characterized by redundant skin forming deep furrows and convolutions. It has been associated with several systemic and cutaneous disorders. We report a case of primary non-essential cutis verticis gyrata in association with acne keloidalis nuchae in a schizophrenic patient.


Subject(s)
Acne Keloid/complications , Scalp Dermatoses/complications , Acne Keloid/pathology , Acne Keloid/therapy , Adult , Anti-Bacterial Agents/therapeutic use , Cryotherapy , Glucocorticoids/therapeutic use , Humans , Male , Scalp Dermatoses/pathology , Schizophrenia , Triamcinolone/therapeutic use
19.
Australas J Dermatol ; 62(3): 354-359, 2021 Aug.
Article in English | MEDLINE | ID: mdl-34176119

ABSTRACT

BACKGROUND: The scalp is a special anatomical area and dermoscopic findings of this region may significantly differ from other body parts. OBJECTIVE: To investigate and compare the clinical and dermoscopic patterns of scalp melanocytic nevi in patients ≤15 years of age and above, and to analyse their relevance to demographic features, atypical mole syndrome (AMS) and total body nevus count (TBNC). METHODS: In this retrospective cohort study, the clinical data and dermoscopic images of patients with scalp melanocytic nevi were retrieved, reviewed and analysed. Demographic, clinical and dermoscopic features were compared in patients ≤15 years of age and above. RESULTS: A total of 196 scalp melanocytic nevi in 126 patients (female/male:64/62; ≤15/>15 years of age: 49/77) with a median age of 18.5 years (range 0-72) were evaluated. Statistically, the globular pattern was significantly higher in all age groups, and the papillomatous pattern was significantly lower in patients ≤15 years of age (P = 0.008 and P = 0.005, respectively). The eclipse pattern was significantly higher, and the homogenous pattern was significantly lower in patients ≤15 years of age with AMS (P = 0.003 and P = 0.014, respectively). Finally, patients ≤15 years of age with 50 to 100 TBNC had a higher eclipse pattern than those with 0 to 25 TBNC. CONCLUSION: The findings of this retrospective study might implicate that children with eclipse pattern of scalp melanocytic nevi might be 'moley' in the future with an impending risk of AMS. This hypothesis requires confirmation in future prospective studies on a larger cohort of patients.


Subject(s)
Nevus, Pigmented/diagnosis , Scalp Dermatoses/diagnosis , Skin Neoplasms/diagnosis , Adolescent , Child , Child, Preschool , Female , Humans , Infant , Male , Nevus, Pigmented/epidemiology , Nevus, Pigmented/pathology , Retrospective Studies , Scalp Dermatoses/epidemiology , Scalp Dermatoses/pathology , Skin Neoplasms/epidemiology , Skin Neoplasms/pathology
20.
Clin Exp Dermatol ; 46(6): 1016-1022, 2021 Aug.
Article in English | MEDLINE | ID: mdl-33882159

ABSTRACT

Dermatomyositis (DM) is an autoimmune connective tissue disease that is included in the idiopathic inflammatory myopathies. Cutaneous manifestations are a prominent part of the condition: some skin signs in DM are common to most patients, while other signs are encountered infrequently. A number of features are pathognomic for DM. The demonstration of myositis-specific antibodies (MSAs) in DM has extended the ability to define phenotypic subgroups. It appears that the presence of certain MSAs confers susceptibility to specific clinical features, an association which reveals a serotype-phenotype relationship. In this review article we have provided a detailed summary of common and under-recognized cutaneous manifestations of DM.


Subject(s)
Dermatomyositis/pathology , Exanthema/pathology , Calcinosis/etiology , Dermatomyositis/complications , Facial Dermatoses/pathology , Hand Dermatoses/pathology , Humans , Leg Dermatoses/pathology , Panniculitis/etiology , Scalp Dermatoses/pathology , Torso/pathology
SELECTION OF CITATIONS
SEARCH DETAIL
...